BlackRock, Inc. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-24 2:30 pm Purchase | 2025-03-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | BlackRock Inc. BLK | 3,226,286 4.600% | 103,716 (+3.32%) | Filing |
| 2024-11-12 11:46 am Unchanged | 2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT | BlackRock Inc. BLK | 3,122,570 5.200% | 0 (Unchanged) | Filing |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT | BlackRock Inc. BLK | 3,122,570 5.200% | 3,122,570 (New Position) | Filing |